Creative Medical Technology Holdings (CELZ) Shares Issued (2017 - 2026)
Creative Medical Technology Holdings (CELZ) posted quarterly Shares Issued of $11183.0 for Q1 2026, little changed year-over-year from $11183.0 in Q1 2025, and little changed quarter-over-quarter from $11183.0 in Q4 2025.
Creative Medical Technology Holdings (CELZ) Shares Issued (2017 - 2026) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Shares Issued for 10 consecutive years, with $11183.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Issued changed 0.0% year-over-year to $11183.0; the TTM figure through Mar 2026 stood at $11183.0 (changed 0.0% YoY), while the FY2025 annual figure was $11183.0, changed 0.0% from the prior year.
- Shares Issued was little changed at $11183.0 in Q1 2026 per CELZ's latest filing, from $11183.0 in the prior quarter.
- Across five years, Shares Issued topped out at $23.0 million in Q2 2022 and bottomed at $11183.0 in Q4 2022.
- Historically, Shares Issued has averaged $1.5 million across 5 years, with a median of $11183.0 in 2022.
- Annual changes were most pronounced in 2022 — Shares Issued jumped 1118200.0% — and 2023, when it tumbled 99.95%.
- Creative Medical Technology Holdings' Shares Issued stood at $11183.0 in 2022, then changed by 0.0% to $11183.0 in 2023, then changed by 0.0% to $11183.0 in 2024, then changed by 0.0% to $11183.0 in 2025, then changed by 0.0% to $11183.0 in 2026.
- Business Quant data shows CELZ's Shares Issued at $11183.0 in Q1 2026, $11183.0 in Q4 2025, and $11183.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.77 Bn | 131.91 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.36 Bn | 60.17 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.60 Bn | 54.47 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.13 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Creative Medical Technology Holdings | 1.80 Mn | 1.80 Mn | - | 11,183.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11,183.00 |
| Jun 30, 2026 | 11,183.00 |
| Mar 31, 2026 | 11,183.00 |
| Mar 31, 2026 | 11,183.00 |
| Dec 31, 2025 | 11,183.00 |
| Dec 31, 2025 | 11,183.00 |
| Sep 30, 2025 | 11,183.00 |
| Sep 30, 2025 | 11,183.00 |
| Jun 30, 2025 | 11,183.00 |
| Jun 30, 2025 | 11,183.00 |
| Mar 31, 2025 | 11,183.00 |
| Mar 31, 2025 | 11,183.00 |
| Dec 31, 2024 | 11,183.00 |
| Dec 31, 2024 | 11,183.00 |
| Sep 30, 2024 | 11,183.00 |
| Sep 30, 2024 | 11,183.00 |
| Jun 30, 2024 | 11,183.00 |
| Jun 30, 2024 | 11,183.00 |
| Mar 31, 2024 | 11,183.00 |
| Mar 31, 2024 | 11,183.00 |